Doctor ... Will I still be able to have children?

Journal of the National Cancer Institute

Volumn 97, Issue 21, 2005, Pages 1557-1559

  Saxman, Scott ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PLATINUM DERIVATIVE;

CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; EVIDENCE BASED MEDICINE; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MALE FERTILITY; MALE INFERTILITY; MEDICAL DECISION MAKING; ORCHIECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION; RETROGRADE EJACULATION; RISK ASSESSMENT; SEMINOMA; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT PLANNING;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; FERTILITY; FERTILIZATION; FOLLOW-UP STUDIES; HUMANS; MALE; QUESTIONNAIRES; REPRODUCTIVE TECHNIQUES, ASSISTED; SURVIVORS; TESTICULAR NEOPLASMS; UNITED STATES;

EID: 27944498970     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji387     Document Type: Editorial

References (12)

1. SEER Cancer Statistics: Estimated New Cancer Cases and Deaths for 2005. Available at: http://seer.cancer.gov/statfacts/html/ testis.html?statfacts_page=testis.html&x=12&y=12.
2. Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005;97:1580-8.
3. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): Modifications of technique and impact on ejaculation. J Urol 1993;149: 237-43.
4. Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999;17:1146-54.
5. Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 2005;23:1200-8.
6. Jones RH, Vasey PA. Part II: Testicular cancer - management of advanced disease. Lancet Oncol 2003;4:738-47.
7. Jones RH, Vasey PA. Part I: Testicular cancer - management of early disease. Lancet Oncol 2003;4:730-7.
8. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer 2005;93:200-7.
9. Foster RS, McNulty A, Rubin LR, Bennett R, Rowland RG, Sledge GW, et al. The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection. J Urol 1994;152: 1139-42.
10. Coogan CL, Hejase MJ, Wahle GR, Foster RS, Rowland RG, Bihrle R, et al. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol 1996;156:1656-8.
11. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 2002;20:4448-52.
12. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992;10:1762-8.